Claudine E. Bruck's most recent trade in Annovis Bio Inc was a trade of 26,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annovis Bio Inc | Claudine E. Bruck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 26,200 | 26,200 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Claudine E. Bruck | Director | Grant, award, or other acquisition of securities at price $ 12.61 per share. | 07 Apr 2023 | 500 | 6,567 (0%) | 0% | 12.6 | 6,305 | Common Stock |
| Annovis Bio Inc | Claudine E. Bruck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 5,967 | 5,967 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Claudine E. Bruck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Claudine E. Bruck | Director | Purchase of securities on an exchange or from another person at price $ 27.66 per share. | 11 Oct 2021 | 181 | 6,067 (0%) | 0% | 27.7 | 5,006 | Common Stock |
| Annovis Bio Inc | Claudine E. Bruck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2021 | 4,000 | 4,000 | - | - | Stock Option (right to buy) |